Pfizer, BioNTech Ask US FDA to Clear Updated COVID-19 Vaccine for Babies and Toddlers

Pfizer, BioNTech Ask US FDA to Clear Updated COVID-19 Vaccine for Babies and Toddlers
Pfizer CEO Albert Bourla in Davos on May 25, 2022. Fabrice Coffrini/AFP via Getty Images
Zachary Stieber
Updated:

Pfizer and its German partner have asked U.S. regulators to clear their updated COVID-19 vaccine for children as young as 6 months of age, the companies announced on Dec. 5.

The companies want emergency clearance for the administration of the new shot as a third dose to children aged 6 months to 4 years.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics